Skip to main content
Figure 1 | Critical Care

Figure 1

From: The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

Figure 1

Exogenous glucagon-like peptide-1 (GLP-1) attenuated the rise in blood glucose levels and the overall glycaemic response to intra-duodenal nutrient infusion. (AUC30–270 min GLP-1 2077 ± 144 mmol/l min vs. placebo 2568 ± 208 mmol/l min; P = 0.02). Data are mean ± SEM (n = 7). * P < 0.05.

Back to article page